176 related articles for article (PubMed ID: 21956730)
1. Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d binding.
Sanderson JP; Waldburger-Hauri K; Garzón D; Matulis G; Mansour S; Pumphrey NJ; Lissin N; Villiger PM; Jakobsen B; Faraldo-Gómez JD; Gadola SD
Eur J Immunol; 2012 Jan; 42(1):248-55. PubMed ID: 21956730
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.
López-Sagaseta J; Kung JE; Savage PB; Gumperz J; Adams EJ
PLoS Biol; 2012; 10(10):e1001412. PubMed ID: 23109910
[TBL] [Abstract][Full Text] [Related]
3. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors.
Brigl M; van den Elzen P; Chen X; Meyers JH; Wu D; Wong CH; Reddington F; Illarianov PA; Besra GS; Brenner MB; Gumperz JE
J Immunol; 2006 Mar; 176(6):3625-34. PubMed ID: 16517731
[TBL] [Abstract][Full Text] [Related]
4. The hypervariable region 4 (HV4) and position 93 of the α chain modulate CD1d-glycolipid binding of iNKT TCRs.
Paletta D; Fichtner AS; Hahn AM; Starick L; Beyersdorf N; Monzon-Casanova E; Mueller TD; Herrmann T
Eur J Immunol; 2015 Jul; 45(7):2122-33. PubMed ID: 25900449
[TBL] [Abstract][Full Text] [Related]
5. Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs.
Chamoto K; Guo T; Scally SW; Kagoya Y; Anczurowski M; Wang CH; Rahman MA; Saso K; Butler MO; Chiu PP; Julien JP; Hirano N
J Immunol; 2017 Feb; 198(3):1056-1065. PubMed ID: 28003379
[TBL] [Abstract][Full Text] [Related]
6. Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.
Matulis G; Sanderson JP; Lissin NM; Asparuhova MB; Bommineni GR; Schümperli D; Schmidt RR; Villiger PM; Jakobsen BK; Gadola SD
PLoS Biol; 2010 Jun; 8(6):e1000402. PubMed ID: 20585371
[TBL] [Abstract][Full Text] [Related]
7. Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors.
Guo T; Chamoto K; Nakatsugawa M; Ochi T; Yamashita Y; Anczurowski M; Butler MO; Hirano N
PLoS One; 2016; 11(5):e0156114. PubMed ID: 27213277
[TBL] [Abstract][Full Text] [Related]
8. Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor.
López-Sagaseta J; Sibener LV; Kung JE; Gumperz J; Adams EJ
EMBO J; 2012 Apr; 31(8):2047-59. PubMed ID: 22395072
[TBL] [Abstract][Full Text] [Related]
9. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
10. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.
Yu ED; Girardi E; Wang J; Mac TT; Yu KO; Van Calenbergh S; Porcelli SA; Zajonc DM
J Biol Chem; 2012 Jan; 287(2):1269-78. PubMed ID: 22110136
[TBL] [Abstract][Full Text] [Related]
12. Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.
Li X; Shiratsuchi T; Chen G; Dellabona P; Casorati G; Franck RW; Tsuji M
J Immunol; 2009 Oct; 183(7):4415-21. PubMed ID: 19734232
[TBL] [Abstract][Full Text] [Related]
13. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
[TBL] [Abstract][Full Text] [Related]
14. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex.
Wun KS; Ross F; Patel O; Besra GS; Porcelli SA; Richardson SK; Keshipeddy S; Howell AR; Godfrey DI; Rossjohn J
J Biol Chem; 2012 Nov; 287(46):39139-48. PubMed ID: 22995911
[TBL] [Abstract][Full Text] [Related]
15. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
Lawson V
Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
Jervis PJ; Polzella P; Wojno J; Jukes JP; Ghadbane H; Garcia Diaz YR; Besra GS; Cerundolo V; Cox LR
Bioconjug Chem; 2013 Apr; 24(4):586-94. PubMed ID: 23458425
[TBL] [Abstract][Full Text] [Related]
17. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
Pellicci DG; Patel O; Kjer-Nielsen L; Pang SS; Sullivan LC; Kyparissoudis K; Brooks AG; Reid HH; Gras S; Lucet IS; Koh R; Smyth MJ; Mallevaey T; Matsuda JL; Gapin L; McCluskey J; Godfrey DI; Rossjohn J
Immunity; 2009 Jul; 31(1):47-59. PubMed ID: 19592275
[TBL] [Abstract][Full Text] [Related]
18. CD1d-independent activation of invariant natural killer T cells by staphylococcal enterotoxin B through major histocompatibility complex class II/T cell receptor interaction results in acute lung injury.
Rieder SA; Nagarkatti P; Nagarkatti M
Infect Immun; 2011 Aug; 79(8):3141-8. PubMed ID: 21628519
[TBL] [Abstract][Full Text] [Related]
19. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.
Li X; Fujio M; Imamura M; Wu D; Vasan S; Wong CH; Ho DD; Tsuji M
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13010-5. PubMed ID: 20616071
[TBL] [Abstract][Full Text] [Related]
20. Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.
Gadola SD; Koch M; Marles-Wright J; Lissin NM; Shepherd D; Matulis G; Harlos K; Villiger PM; Stuart DI; Jakobsen BK; Cerundolo V; Jones EY
J Exp Med; 2006 Mar; 203(3):699-710. PubMed ID: 16520393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]